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Casein kinase II purified from nuclei of Xenopus laevis oocytes is inhibited by several specific nucleic acids. This kinase, 
the main phosphorylating activity of the oocyte nucleus, is markedly inhibited by poly U at 10 pg/ml, and this polymer 
is a competitive inhibitor of the phosporylation of the substrate casein (Kiapp 80 nM). M 13 phage ssDNA and unfrac- 
tionated yeast RNA also inhibit between 50 and 200 pg/ml. Poly C, poly A, poly AG, dsDNA and Escherichiu co/i rRNA 
do not alter activity significantly at similar concentrations. Inhibitions are reversed by RNase (poly U, tRNA) or S, nucle- 
ase &DNA). Oocyte casein kinase I or rabbit CAMP-dependent protein kinase are not inhibited by poly U at 200 pg/ml. 
The sensitivity of the casein kinase II to these inhibitors suggests a regulatory role for nucleic acids in nuclear phosphoryl- 
ation reactions. 
Protein kinase; Poly U; DNA, single-stranded, tRNA; Nucleus; (Xenopus luevis) 
1. INTRODUCTION 
Protein phosphorylation-dephosphorylation sys- 
tems are among the most important mechanisms 
for the regulation of biological activity. A large 
number of unique members of the protein kinase 
family have been described, one of the most in- 
teresting and ubiquitous being casein kinase II (for 
review see [l]). Casein kinase II phosphorylates 
acidic proteins using either ATP or GTP as phos- 
phoryl donor and is the major protein phos- 
phorylating activity detected in the nuclei of am- 
phibian oocytes [2]. The enzyme can be activated 
by polyamines and polylysine, and it is susceptible 
to the inhibition by heparin at concentrations of 
1 pg/ml. The inhibition by heparin is competitive 
with the protein substrates [3] and its efficiency 
depends on the nature of that substrate [4,5]. An 
explanation for the potency of inhibition by 
heparin can be deduced from the studies by the 
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groups of Krebs and Pinna [6,7], who established 
the structural requirements for model peptide sub- 
strates of casein kinase II. Their results indicate 
that this enzyme phosphorylates serines or 
threonines that are followed by clusters of the 
acidic side chains of aspartic and glutamic acids, or 
by previously phosphorylated amino acids. The 
laboratory of Pinna has also shown that poly- 
glutamic and polyaspartic acids are strong in- 
hibitors of casein kinase II [7]. 
The function of casein kinase II in the nuclei of 
cells has not been elucidated. However, there are 
several ines of evidence that implicate this enzyme 
in the regulation of the synthesis of nucleic acids 
[5,8-111. Zandomeni et al. have obtained results 
that suggest hat casein kinase II may be playing a 
role in the initiation of transcription by RNA 
polymerase II [ 121. 
The affinity of casein kinase II for polyanions 
and its presence in the nucleus raises the question 
of whether the enzyme could be interacting with 
nucleic acids and whether this interaction could 
regulate its activity. Previous reports have im- 
plicated that nucleic acids [ 13-151 or oligo- 
nucleotides [16] may inhibit enzymes with proper- 
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ties of casein kinase II. In this communication, we 
present data that demonstrate that poly U, tRNA 
and single-stranded DNA can act as strong in- 
hibitors of the casein kinase II obtained from the 
nuclei of Xenopzis faevis oocytes. 
2. MATERIALS AND METHODS 
[Y-~‘P]ATP was prepared by the method of Walseth and 
Johnson [17] using 32P from Amersham. Yeast tRNA was from 
Calbiochem, E. coli ribosomal RNA and Si nuclease were from 
Boehringer, pGEM-3 from Promega and Ml3 RF DNA from 
Bethesda Research Laboratories. Oligo dT (12-18mer) was 
from Collaborative Research. tRNAPhe was kindly donated by 
H. Sternbach (MPI, Goettingen). Poly U, poly A, poly C and 
poly AG (all > 100 kDa), nucleotides, nucleases, salmon sperm 
DNA, spermine, protamine and cup-de~ndent protein 
kinase (rabbit muscle) were from Sigma. Nucleic acids and 
nucleotides were dissolved in distilled water and the pH adjusted 
as necessary. Dephosphorylated casein used in all assays was 
prepared as described [3]. 
Ovaries were obtained by surgery from adult female X. laevis. 
Stage 5 and 6 oocytes and nuclei were prepared as described by 
Burzio and Koide [18]. Casein kinase II was purified from 
cytosol-free nuclei by chromatography on DEAE-Sephadex [2] 
and phosphocellulose [5] as described originally by Hathaway 
and Traugh [19]. Casein kinase I was obtained from the nuclear 
extracts using DEAE-Sephadex chromatography [2]. 
Casein kinuse ZZ assay: reactions (50~1) contained 40 mM 
Hepes, pH 7.7, 180 mM KCl, 10 mM MgClz, 50pM dithio- 
threitol, and 50 PM [y-“P]ATP (700-900 cpm/pmol). All 
assays contained 80-100 U/ml of casein kinase II [5] and 
0.5 mg/ml dephosphocasein except where indicated otherwise. 
All additions were made prior to the addition of the enzyme. In- 
cubation times were routinely for 15 min at 30°C and the reac- 
tion was linear for at least 30 min. The reaction was terminated 
by the removal of an aliquot to a 2 x 1 cm Whatman P81 phos- 
phocellulose paper which was immersed in 75 mM phosphoric 
acid, washed 3 times in the same acid, dried and counted. Values 
reported have been corrected for controls run with heat 
denatured enzyme. All assays were performed in triplicate and 
are representative of 2-4 experiments. 
The results obtained for the inhibition of casein phosphoryla- 
tion in the presence and absence of poly U were analyzed for 
both mixed and competitive inhibition using the program 
NATO adapted to an IBM-PC as described by Cornish-Bowden 
[20]. The best fit fot the experimental data was obtained for 
competitive inhibition. 
3. RESULTS 
The addition of single-str~ded M 13 phage DNA 
to the standard assay of pure casein kinase II 
prepared from X. laevis oocyte nuclei results in 
marked inhibition of enzyme activity. As shown in 
fig.1, the phosphorylation of the exogenous sub- 
strate casein was 50% inhibited at a concentration 
er : 50 I \ c a, 
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Fig. 1. The effect of phage DNA on nuclear casein kinase II from 
X. laevis oocytes. Reactions were carried out using the standard 
condition described in section 2 and 80 U/ml of casein kinase II, 
with the following additions: 0, single-stranded Ml3 DNA; 
A , double-stranded Ml3 DNA; and l , double-stranded 
pGEM-3 DNA. 
of about 50 pg/ml. Double-stranded Ml3 DNA 
was much less effective and the DNA of phage 
pCEM-3 did not cause inhibition at over 200 agfml 
and was found to stimulate 15-20070 over control 
values. Total DNA from salmon sperm did not 
alter activity. 
Unfractionated yeast tRNA which contains a 
mixture of the different amino acid acceptor 
species inhibits the enzyme, showing 50% inhibi- 
tion at 150pg/ml (fig.2). A similar result was ob- 
tained with total oocyte tRNA (not shown). 
Specific tRNAPhe, however, did not inhibit and was 
even slightly stimulatory at the higher levels tested. 
E. coli 16s and 26s ribosomal RNA, on the other 
hand, did not alter the kinase activity. 
These initial observations suggested that the in- 
hibitory effect was limited to particular nucleic 
acid structures and not simply related to the poly- 
anionic nature of these compounds. The results ob- 
tained with synthetic polynucleotides confirmed 
this supposition. Fig.3 shows the results obtained 
with 3 high molecular weight homopolymers. Poly 
U is seen to be a potent inhibitor of the enzyme, 
giving 50% inhibition at approximately 10 aglml, 
while poly C is much less effective and poly A and 
poly AG (not shown) are without effect over the 
wide range of concentrations tested. The capacity 
of oligo dT, between 12-18 bases in length, and the 
trinucleotides ACC and AUU were also tested (not 
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Fig.2. The effect of tRNA and rRNA on nuclear casein kinase 
II from X. Zuevis oocytes. Reactions were carried out as in fig. 1 
with the following additions: n , yeast tRNAPhc; l , yeast total 
tRNA; and 0, E. coli 16s and 23s rRNA. 
shown). Only the triplet AUU had a significant ef- 
fect, inhibiting 30% at 4 A&ml. 
The nature of the inhibitory effect was analyzed 
further by the use of specific nucleases. As shown 
in table 1 the presence of pancreatic ribonuclease 
added during the 15 min assay period reverses the 
inhibitory effect of poly U, whereas DNase has no 
effect. Inhibition by tRNA was also reverted by 
RNase A. The inhibitory effect of single-stranded 
DNA from Ml3 is greatly reduced by Sl nuclease, 
whose activity is specific for single-stranded nucleic 
acids. 
The capacity of poly U to inhibit in the presence 
of polyamines was also evaluated. As shown in 
table 1, the kinase activity is stimulated in a typical 
manner by spermine at 1.5 mM but this agent does 
not override the inhibitory effect of poly U 
(estimated 100 PM). The lack of complete reversal 
by the addition of a high concentration of RNase is 
surprising and may indicate that the poly U is not 
accessible to the nuclease under these conditions. 
The velocity of the casein kinase II phos- 
phorylating reaction was measured using different 
concentrations of casein in the presence and 
absence of poly U. The double reciprocal plot 
shown in fig.4 indicates that the poly U inhibition 
is competitive with the protein substrate with an 
apparent inhibition constant of 82 .nM. 
Casein kinase I is also present in oocyte nuclei 
and may be separated chromatographically from 
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Fig.3. The effect of synthetic polynucleotides on nuclear casein 
kinase II from X. laevis oocytes. Reactions were carried out as 
in fig. 1 with the following additions: 0, poly A; q , poly C; 0, 
poly u. 
casein kinase II [2,18]. Such a preparation was 
tested for the capacity to be inhibited by poly U 
and was found to have unaltered activity in the 
presence of lo-200 pg/ml of the polynucleotide 
(not shown). CAMP-dependent protein kinase was 
Table 1 
Characteristics of the inhibition of casein kinase II by nucleic 
acids 
Experiment Addition Activity 
Vol 
1. None 100 
Poly u 28 
RNase 94 
Poly U and RNase 86 
DNase 96 
Poly U and DNase 25 
2. None 100 
Ml3 ssDNA 30 
Nuclease S 1 100 
Ml3 ssDNA and nuclease Sl 16 
3. None 100 
Poly u 27 
Spermine 174 
Poly U and spermine 19 
Poly U, spermine and RNase 89 
Reactions were carried out under standard conditions described 
in section 2. The additions were made to give the following final 
concentrations: poly U and Ml3 single-stranded DNA (ssDNA), 
100 pg/ml; nuclease Sl, 60 U/ml; pancreatic RNase and DNase, 
20 pg/ml; and spermine, 1.5 mM 
416 
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Fig.4. Double reciprocal plot of the inhibition of oocyte nuclear 
casein kinase II by poly U. Casein was varied from 0.5 to 
18 mg/ml and ATP concentration was constant at 50 PM. In- 
cubations were for 10 min, using otherwise standard conditions 
as given in section 2, in the presence (e) or absence (0) of poiy 
U at 8.5 ,ug/ml. 
likewise unaffected by similar concentrations of 
poly U when assayed with protamine as substrate. 
4. DISCUSSION 
The activity of casein kinase II from most 
sources studied is characteristically affected by two 
classes of agents, polyanionic compounds such as 
heparin, a potent inhibitor [3], and polycationic 
agents such as polylysine and spermine, which ac- 
tivate the enzyme 1211. The results presented in this 
communization demonstrate that specific nucleic 
acids can also inhibit casein kinase II. 
This observation extends the initial findings of 
Kandrov and Stepanov 1141 who reported that a 
protein phosphorylating activity obtained from 
oocytes of 
U-Sepharose columns and that 
poly U was inhibitory to the phosphorylation 
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